Advanced Or Metastasic Triple Negative Breast Cancer clinical trials

Explore recruiting advanced or metastasic triple negative breast cancer clinical trials.

Also recruiting in Europe

Advanced Or Metastasic Triple Negative Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Treatment of advanced or metastatic triple negative breast cancer with tumor infiltrating lymphocytes (TILs).

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Advanced Or Metastasic Triple Negative Breast Cancer trials by city

Advanced Or Metastasic Triple Negative Breast Cancer in Toronto Advanced Or Metastasic Triple Negative Breast Cancer in Vancouver Advanced Or Metastasic Triple Negative Breast Cancer in Montreal Advanced Or Metastasic Triple Negative Breast Cancer in Calgary Advanced Or Metastasic Triple Negative Breast Cancer in Edmonton Advanced Or Metastasic Triple Negative Breast Cancer in Ottawa Advanced Or Metastasic Triple Negative Breast Cancer in Winnipeg Advanced Or Metastasic Triple Negative Breast Cancer in Quebec City Advanced Or Metastasic Triple Negative Breast Cancer in Hamilton Advanced Or Metastasic Triple Negative Breast Cancer in Kitchener Advanced Or Metastasic Triple Negative Breast Cancer in London Advanced Or Metastasic Triple Negative Breast Cancer in Halifax Advanced Or Metastasic Triple Negative Breast Cancer in New York Advanced Or Metastasic Triple Negative Breast Cancer in Los Angeles Advanced Or Metastasic Triple Negative Breast Cancer in Chicago Advanced Or Metastasic Triple Negative Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease